Point72 Asset Management
BEAT

Point72 Asset Management’s BioTelemetry, Inc. BEAT Stock Holding History

Point72 Asset Management’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-97,554
Closed -$5.83M – 1347
2018
Q4 		$5.83M Buy
97,554
+5,454
+6% +$327K 0.03% 522
2018
Q3 		$5.94M Buy
92,100
+70,800
+332% +$3.95M 0.02% 556
2018
Q2 		$959K Sell
21,300
-32,600
-60% -$1.3M ﹤0.01% 834
2018
Q1 		$1.67M Buy
+53,900
New +$1.77M 0.01% 756

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Point72 Asset Management's BEAT Position: Q1 2019 in Review

Point72 Asset Management sold out of BioTelemetry, Inc. (BEAT) in Q1 2019, closing a stake of 97,554 shares — an estimated $5.83M sold.

Point72 Asset Management first reported a position in BEAT in Q1 2018 and held it in 4 quarters. The position peaked at $5.94M in Q3 2018. 311 funds tracked by Wall St. Rank hold BEAT as of Q1 2019.

  • Point72 Asset Management reported no remaining BioTelemetry, Inc. position as of Q1 2019 after selling out during the quarter.
  • Point72 Asset Management sold 97,554 BioTelemetry, Inc. shares in Q1 2019, an estimated $5.83M.
  • Point72 Asset Management first reported a position in BioTelemetry, Inc. in Q1 2018 and held it in 4 quarters.
  • Point72 Asset Management's BioTelemetry, Inc. position peaked at $5.94M in Q3 2018.
  • 311 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2019.

Based on Point72 Asset Management's 13F filing for Q1 2019, filed 15 May 2019.